We implanted MYC-driven luciferase-labeled 4188 cells in recipient mice and observed a reduction in tumor burden for TOFA-treated mice, measured by bioluminescence imaging (BLI) (Fig. 5A), confirming that MYC-dependent cells are metabolically sensitive to lipogenesis inhibition in vivo. This evidence concerns the gene MYC and neoplasm.